Clinical Trials Logo

Clinical Trial Summary

A single blind, multi-center, randomized study is preformed to compare NOYA CoCr biodegradable coating sirolimus-eluting stents with Firebird2 drug-eluting stents from MicroPort Medical (Shanghai) Co., Ltd. to evaluate the safety and efficacy of NOYA CoCr biodegradable coating sirolimus-eluting stents in treating coronary artery lesions.


Clinical Trial Description

A single blind, multi-center, randomized study is preformed to compare NOYA CoCr biodegradable coating sirolimus-eluting stents with Firebird2 drug-eluting stents from MicroPort Medical (Shanghai) Co., Ltd. to evaluate the safety and efficacy of NOYA CoCr biodegradable coating sirolimus-eluting stents in treating coronary artery lesions. Appropriate patients judged by inclusion and exclusion standards will be preformed stent implantation, and after that all patients will be clinically followed up at 30, 90, 180, 270,365 days,2 years,3 years,4 years and 5 years. Especially, standard quantity coronary angiography (QCA) will be conducted at 270 days (±30days) through which the main therapeutic indicator of late luminal loss (LLL) is obtained so as to evaluate the efficacy of tested stents. Major adverse cardiac events (MACEs) found in following-up period as key indicators to evaluate the safety of stents. The arrangement, conclusion and statistical analysis of trial data including clinography and angiography will be fulfilled by independent Data Management Center(DMC) and radiography core laboratory. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01226355
Study type Interventional
Source Medfavour (Beijing) Medical Co., Ltd
Contact
Status Active, not recruiting
Phase N/A
Start date April 2009
Completion date November 2014

See also
  Status Clinical Trial Phase
Completed NCT00328315 - Cardiac SPECT With Rotating Slant Hole Collimator
Recruiting NCT02257710 - BIOFLOW-III UK Satellite Registry Orsiro Stent System N/A
Active, not recruiting NCT02273648 - BIOTRONIK - BIOFLOW-III Registry French Satellite N/A
Recruiting NCT01157455 - A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization Phase 4
Completed NCT02028728 - BIOFLOW III Satellite-Italy Orsiro Stent System N/A
Completed NCT02813473 - SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease
Completed NCT05853250 - Clinical and Hospital Stay Effects of Reiki and Manual Therapy After Open Heart Surgery N/A
Recruiting NCT02635230 - What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Completed NCT01116882 - Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings N/A
Completed NCT00920283 - COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilmâ„¢ Coated Stent N/A
Completed NCT01700075 - Physical and Chemical Study of Atherosclerosis Mechanisms Phase 4
Completed NCT00607178 - The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases Phase 2/Phase 3
Completed NCT00607217 - The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases Phase 2/Phase 3
Not yet recruiting NCT05486780 - The Effect of Digital Window on Day and Night Perception Status and Sleep Quality in Intensive Care Patients N/A
Terminated NCT01665248 - Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina N/A
Terminated NCT01612819 - DXR Stent(Previous Cilotax) Implantation Registry N/A
Recruiting NCT02247492 - BIOFLOW-III VIP Russia Registry Orsiro Stent System